veterinary drug
ᴾᴿHemophyt®
Film-coated tablet containing phytomenadione (Ph. Eur.), a vitamin K1 used as an antidote following the ingestion of vitamin K antagonist anticoagulants in dogs.
Active ingredient:PhytomEnadione (Vitamin K1)
- Concentration: 50 mg/tablet
- Administration : oral
- Dosage: 5 mg/kg once daily for a minimum of 21 days (1 tablet per 10 kg per day).
Box contents:12 x 7 comprimés
Part of the range
Indications
- For the maintenance treatment of anticoagulant poisoning in dogs following emergency vitamin K1 parenteral treatment in the presence of clinical coagulopathy1;
- As a sole agent for the treatment of subclinical coagulopathy caused by anticoagulant poisoning.
How to administer ᴾᴿHemophyt®?
- Each tablet contains 50mg of phytomenadione (vitamin K1).
- For oral use at 5 mg/kg once daily for a minimum of 21 days (1 tablet per 10 kg per day).
- Administer the tablets 30 to 60 minutes after a meal.
- Tablets that can be broken into halves and quarters.
- Store between 15 and 30°C in the original packaging, away from light. Any unused divided tablet should be discarded after 3 days.
Specifications
Regulatory
- DIN: DIN 02539314
- Prescription required (Canada): Yes
- Prescription required (Quebec): Yes
- WHMIS: No
- Cytotoxic: No
Physics
- Package length: 11.3 cm
- Packaging width: 9.9 cm
- Packaging height: 5.3 cm
- Package weight: 0.13 kg
- Unilingual packaging: No
¹Clinical coagulopathy is defined as the presence of bleeding that may occur at one or more sites, associated with a prolonged prothrombin time (PT) phase.
Subclinical coagulopathy is defined as mild coagulopathy (≥ 20% increase in the upper reference range of PT) occurring in the early phase of anticoagulant poisoning, when dogs show no clinical signs.